ArticleLeukemia2015

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.

D Guinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.